UPDATE: Biogen Idec (BIIB) Completes Strategic Review Without Sale

December 12, 2007 4:21 PM EST Send to a Friend
Biogen Idec Inc. (NASDAQ: BIIB) said The Board of Directors of complated the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login